Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05321160
Other study ID # EA and esketamine
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 28, 2022
Est. completion date May 17, 2023

Study information

Verified date March 2024
Source Eye & ENT Hospital of Fudan University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Emergence agitation is the most common reason for post-anesthesia care unit delay. Sevoflurane is used frequently inhalational anaesthetic agent to provide pediatric anaesthesia because of the nonirritant nature. It has been successfully used for keeping spontaneous breathing without tracheal intubation. However, sevoflurane may cause emergence agitation as the incidence varied from 10%-80%. Although there are many sedative agents to reduce its incidence, such as propofol, midazolam, a2 adrenergic receptor agonists and ketamine, the efficacy remains limited. Ketamine, a neuroleptic anesthetic agent, contains two optical isomers, s(+)-ketamine (esketamine) and R(-)-ketamine. Esketamine is a right-handed split of ketamine, which has enhanced analgesic potency and lower incidence of psychotropic side effects compared to ketamine. It stimulate breathing due to N-Methyl-D-Aspartate receptor blockade, and could even effectively countered remifentanil-induced respiratory depression. The investigators compared the effectiveness of esketamine and sevoflurane in reducing the incidence of emergence agitation after painless ophthalmological procedure in pediatric patients.


Description:

Ophthalmological procedure such as suture remove, intraocular pressure (IOP) measurement, slit-lamp and fundoscopy are most frequently performed in operation with minor surgical stimulus, and the the duration of surgery is very short. Several anesthestic agents are available,but it is hard to balance short effect and fast rotation in post-anesthesia care unit. Emergence agitation is the most common reason for post-anesthesia care unit delay. Sevoflurane is used frequently inhalational anaesthetic agent to provide pediatric anaesthesia because of the nonirritant nature. It has been successfully used for keeping spontaneous breathing without tracheal intubation. However, sevoflurane may cause emergence agitation as the incidence varied from 10%-80%. Although there are many sedative agents to reduce its incidence, such as propofol, midazolam, a2 adrenergic receptor agonists and ketamine, the efficacy remains limited. Ketamine, a neuroleptic anesthetic agent, contains two optical isomers, s(+)-ketamine (esketamine) and R(-)-ketamine. Esketamine is a right-handed split of ketamine, which has enhanced analgesic potency and lower incidence of psychotropic side effects compared to ketamine. It stimulate breathing due to N-Methyl-D-Aspartate receptor blockade, and could even effectively countered remifentanil-induced respiratory depression. Additionally, several studies have reported ketamine could reduced agitation, but there is no study about esketamine on emergence agitation. The investigators compared the effectiveness of esketamine and sevoflurane in reducing the incidence of emergence agitation after painless ophthalmological procedure in pediatric patients.


Recruitment information / eligibility

Status Completed
Enrollment 116
Est. completion date May 17, 2023
Est. primary completion date May 14, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 3 Months to 5 Years
Eligibility Inclusion Criteria: - American Society of Anesthesiologists physical status 1-2 - required to remove the stitches by microscope after corneal surgeries Exclusion Criteria: - psychiatric disorders - cardiovascular disorders - glaucoma - contraindications to nasal intubation

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Esketamine
0.25 mg/kg esketamine for induction and 0.25 mg/kg esketamine at the beginning of surgery
Sevoflurane
4% sevoflurane for induction and 2-4% sevoflurane for maintain

Locations

Country Name City State
China Anesthesiology Department of Affiliated Eye and ENT Hospital, Fudan University Shanghai Shanghai

Sponsors (1)

Lead Sponsor Collaborator
Eye & ENT Hospital of Fudan University

Country where clinical trial is conducted

China, 

References & Publications (6)

Cravero J, Surgenor S, Whalen K. Emergence agitation in paediatric patients after sevoflurane anaesthesia and no surgery: a comparison with halothane. Paediatr Anaesth. 2000;10(4):419-24. doi: 10.1046/j.1460-9592.2000.00560.x. — View Citation

Eich C, Verhagen-Henning S, Roessler M, Cremer F, Cremer S, Strack M, Russo SG. Low-dose S-ketamine added to propofol anesthesia for magnetic resonance imaging in children is safe and ensures faster recovery--a prospective evaluation. Paediatr Anaesth. 2011 Feb;21(2):176-8. doi: 10.1111/j.1460-9592.2010.03489.x. No abstract available. — View Citation

Liao R, Li JY, Liu GY. Comparison of sevoflurane volatile induction/maintenance anaesthesia and propofol-remifentanil total intravenous anaesthesia for rigid bronchoscopy under spontaneous breathing for tracheal/bronchial foreign body removal in children. Eur J Anaesthesiol. 2010 Nov;27(11):930-4. doi: 10.1097/EJA.0b013e32833d69ad. — View Citation

Patrizi A, Picard N, Simon AJ, Gunner G, Centofante E, Andrews NA, Fagiolini M. Chronic Administration of the N-Methyl-D-Aspartate Receptor Antagonist Ketamine Improves Rett Syndrome Phenotype. Biol Psychiatry. 2016 May 1;79(9):755-764. doi: 10.1016/j.biopsych.2015.08.018. Epub 2015 Aug 24. — View Citation

Welborn LG, Hannallah RS, Norden JM, Ruttimann UE, Callan CM. Comparison of emergence and recovery characteristics of sevoflurane, desflurane, and halothane in pediatric ambulatory patients. Anesth Analg. 1996 Nov;83(5):917-20. doi: 10.1097/00000539-199611000-00005. — View Citation

White PF, Schuttler J, Shafer A, Stanski DR, Horai Y, Trevor AJ. Comparative pharmacology of the ketamine isomers. Studies in volunteers. Br J Anaesth. 1985 Feb;57(2):197-203. doi: 10.1093/bja/57.2.197. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary the incidence of respiratory depression respiratory rate <12 times per min or weak chest undulation duration from the time patient received induction to the time of leaving to the ward, average 1 hour
Primary the incidence of desaturation the incidence of oxygen saturation below 95% caused by anesthetic agent. duration from the time patient received induction to the time of leaving to the ward, average 1 hour
Primary the incidence of hypotension the incidence of systolic blood pressure< 30% of basal systolic blood pressure and lasted >5 minutes. duration from the time patient received induction to the end of the anesthesia, average 15 minutes.
Primary the incidence of hypertension the incidence of systolic blood pressure > 30% of basal systolic blood pressure duration from the time patient received induction to the end of the anesthesia, average 15 minutes.
Primary the incidence of tachycardia the incidence of heart rate increase over 30% of pre-induction and>120 beats per minute. duration from the time patient received induction to the end of the anesthesia, average 15 minutes.
Primary the incidence of bradycardia the incidence of heart rate less than 60 beats per minute duration from the time patient received induction to the end of the anesthesia, average 15 minutes.
Primary the incidence of emergence agitation the incidence of emergence agitation duration from the time patients arrived the post-anesthesia care unit to the time of leaving to the ward, average 20 minutes
Secondary length of stay in the post-anesthesia care unit the time of patients staying in post-anesthesia care unit duration from the time patients arrived the post-anesthesia care unit to the time of leaving to the ward, average 20 minutes
Secondary CPS score The Cole 5-point scale CPS) score included five behaviors: 1=sleeping; 1=awake,calm;3=irritable, crying;4=inconsolable crying; 5=severe restlessness, disorientation. scores at the time point of 1 minutes after extubation
Secondary intraocular pressure intraocular pressure after induction the time after intubation and topical anesthesia within 1 minute
Secondary diastolic pressure diastolic pressure 1minutes before induction; 1minutes before intubation; 1minutes after intubation; 3 minutes after intubation
Secondary systolic pressure systolic pressure 1minutes before induction; 1minutes before intubation; 1minutes after intubation; 3 minutes after intubation
Secondary heart rate heart rate 1minutes before induction; 1minutes before intubation;1minutes after intubation,3 minutes after intubation
Secondary extubation time extubation time duration from the time that patients arrived in post-anesthesia care unit to the time of extubation, average 10 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT03668639 - Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin Phase 2/Phase 3
Completed NCT05232656 - PREventing Adverse Events Post-Discharge Through Proactive Identification, Multidisciplinary Communication, and Technology N/A
Completed NCT03482232 - Consequences of Doing What Should Not be Done in Primary Care
Completed NCT05693051 - Use of Prone Position Ventilation in Danish Patients With COVID-19 Induced Severe ARDS Treated With VV-ECMO
Completed NCT04055363 - Human Milk Oligosaccharides (HMOs) Post-market Study on Infants N/A
Completed NCT05133817 - Prophylactic Norepinephrine Infusion Combined With Colloid Coloading for Postspinal Anesthesia Hypotension N/A
Completed NCT02996201 - Electronic Patient Reporting of Side Effects to Chemotherapy: A Cluster Randomized Controlled Trial N/A
Recruiting NCT05462938 - Conscious Sedation for Transcatheter Aortic Valve Implantation N/A
Completed NCT04562922 - LIFEMEL Efficacy in Preventing Haematopoietic Toxicity in Patients Treated With Chemotherapy Phase 2
Recruiting NCT03740464 - Long-acting G-CSF for Febrile Neutropenia Phase 3
Completed NCT03332433 - High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Gastroscopy Sedated by Propofol N/A
Not yet recruiting NCT04615156 - 18F-2-fluoro-2-deoxy-D-glucose in Positron Emission Tomography Computed Tomography Phase 3
Recruiting NCT03381534 - Safety and Efficacy of Distal Embolic Protection Device in Vertebral Artery Origin Stenting N/A
Completed NCT04570488 - Predicting Favorable Outcomes in Hospitalized Covid-19 Patients
Recruiting NCT05369962 - Adverse Event Prediction in Geriatric Patients in the ED With Ultrasound
Withdrawn NCT03673566 - Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - CHMCO N/A
Completed NCT03745677 - Redesigning Systems to Improve Quality for Hospitalized Patients N/A
Completed NCT04763876 - Intramuscular Ketorolac at Two Single-Dose Regimens Phase 4
Withdrawn NCT03673579 - Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - MHSB N/A
Enrolling by invitation NCT05443217 - Relationship Between Microbiota and Prognosis of Hepatocellular Carcinoma(HCC) After Systemic Treatments